The therapeutic promise of nitric oxide (NO), a potent vasodilator, remains uncertain for
adults, and licensed indications are restricted to pediatric practice. This review considers the
biologic actions of inhaled nitric oxide, the clinical indications for its administration in adults,
and an assessment of its potential therapeutic development.